BridgeMD
New treatment option for Vitamin B 12 Deficiency
Official title Early Infant Micronutrition and Development
ClinicalTrials.gov ID: NCT05005897
What this study is testing
What is Cyanocobalamin?
Cyanocobalamin is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for vitamin b 12 deficiency.
Also referred to as Vitamin B12.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Globally, vitamin B12 deficiency is one of the most common micronutrient deficiencies. Poor status is also seen in affluent countries such as in Norway.
- Phase 3: a large, late-stage study
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 2
You may be able to join if
- Availability of informed verbal consent
- Plan to reside in the defined study area for the next 12 months
- Mothers intend to breastfeed their children for at least 8 months, and exclusively for 4 months
You likely can't join if
- Severe systemic illness requiring hospitalization
- Growth retardation
- Severe congenital malformations
- Plasma cobalamin concentration \<148 pmol/L (These children will be treated for vitamin B12 deficiency and not included in the RCT, but will be...
The study team makes the final eligibility decision.
Where it's taking place
- Lillehammer, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 month to 2 months. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lillehammer, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.